Vu et al. found that m6A could control the translation of PTEN, c-MYC, and BCL2, which are involved in the differentiation of hematopoietic stem/progenitor cells in AML (Vu et al., 2017). This evidence concerns the gene BCL2 and acute myeloid leukemia.